Salute e Benessere

Cosmetic Dentistry Market is expected to generate a revenue of USD 42.79 Billion…

For a detailed analysis of Industry Trends And Growth Drivers, Explore The Full Cosmetic Dentistry Market. For a detailed analysis of Industry Trends And Growth Drivers, Explore The Full Cosmetic Dentistry Market . Browse in-depth TOC 202 - Pages 126 – Tables 37 – Figures Global Cosmetic Dentistry Market Overview Market Driver 1. Rising Demand for Aesthetic Enhancement and Smile Transformation 2. Adoption of Advanced Dental Technologies...
PR Newswire
24/11/2025

Biochips Market worth $21.36 billion by 2030 with 8.8% CAGR | MarketsandMarkets™

Browse in-depth TOC on "Biochips Market" Browse in-depth TOC on "Biochips Market" 300 - Tables65 - Figures 350 - Pages By products & services,the biochips market is categorized into instruments, consumables, and software & services. The consumables segment is projected to grow at the highest CAGR during the forecast period, as biochip technologies generate vast and complex datasets that require advanced analytics and AI-based interpretation. Cloud integration...
PR Newswire
24/11/2025

Menarini Group Announces New Data on ELZONRIS® (tagraxofusp-erzs) to be…

The presentations include an oral session highlighting results from a triplet therapy combining tagraxofusp, azacitidine, and venetoclax, which demonstrated both efficacy (high response and bridge to transplant rates) and tolerability in individuals with blastic plasmacytoid dendritic cell neoplasm (BPDCN). "At Menarini Stemline, our commitment to transforming the lives of people living with difficult-to-treat cancers is unwavering," said Elcin Barker Ergun, CEO of the Menarini…
PR Newswire
24/11/2025

Regenerative Medicine Market to Skyrocket to USD 403.86 Billion by 2032 Driven…

Download PDF Brochure: https://www.datamintelligence.com/download-sample/regenerative-medicine-market Download PDF Brochure:https://www.datamintelligence.com/download-sample/regenerative-medicine-market Browse in-depth TOC on "Regenerative Medicine Market"60 – Tables 50 – Figures 176 – Pages Regenerative Medicine: A New Era of Curative, Transformative Therapies 1. Cell & gene therapy approvals gaining momentum Over the last 36 months, approvals for CAR-T...
PR Newswire
24/11/2025

Alzheimer's Association Statement on Oral Semaglutide Phase 3 Topline Data…

"While these results are not what we had hoped for, they will contribute to our understanding of this devastating and fatal disease," said Joanne Pike, DrPH, Alzheimer's Association president and chief executive officer. "The data from every clinical trial, regardless of outcome, is vital to accelerating our understanding of this disease and helps inform the next generation of clinical trials. We remain optimistic about the future of Alzheimer's treatment and prevention, as the…
PR Newswire
24/11/2025

Philips launches next-generation web-based diagnostic viewer for fast, secure…

New viewer offers full radiology capabilities, interfaces with AI and interactive reporting module to streamline workflows Amsterdam, the Netherlands –Royal Philips(NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of Philips Image Management 15, the next generation of Philips Vue PACS, including a zero-footprint,web diagnostic viewer[1] that transforms how radiologists access and interpret medical images. Designed with a brand-new user...
Nasdaq GlobeNewswire
24/11/2025

Enlivex Announces $212,000,000 Private Placement to Initiate World’s First…

- Upon the closing of the private placement, Enlivex will adopt the world’s first RAIN prediction markets token digital asset treasury strategy, via RAIN token accumulation.- RAIN is a fully decentralized predictions and options protocol that redefines predictive market ecosystems and provides a powerful platform for on-chain market creation - built for transparency, automation, and community participation.- Mr. Matteo Renzi, former Prime Minister of Italy, will be appointed to the...
Nasdaq GlobeNewswire
24/11/2025

Biogen and Dayra Therapeutics Announce Research Collaboration to Discover and…

Oral macrocyclic peptides have the potential to offer biologic-like efficacy and safety in a convenient oral formatCollaboration further advances Biogen’s immunology strategy by broadening its early-stage pipeline and incorporating an additional clinically validated modality into its expanding immunology capabilities CAMBRIDGE, Mass. and TORONTO, Nov.24, 2025(GLOBE NEWSWIRE) --BiogenInc. (Nasdaq: BIIB) and Dayra Therapeutics today announced a research collaboration to discover and...
Nasdaq GlobeNewswire
24/11/2025

Loftware Celebrated Among the World's Top Healthcare Technology Innovators of…

Loftware was selected for its cloud-based labeling and packaging technologies designed to support the complex operational and regulatory demands faced by medical device manufacturers, pharmaceutical companies, and broader life sciences organizations. With increasing global regulatory pressures, from U.S. FDA requirements to EU MDR and global UDI regulations, Loftware enables customers to automate, centralize, and standardize labeling processes while mitigating risk, enhancing traceability, and…
PR Newswire
24/11/2025

Veeva Announces Expanded Partnership with Roche

"Roche and Veeva have partnered for many years," said Veeva CEO Peter Gassner. "We are honored to extend our partnership to Vault CRM and bring the next generation of AI-enabled CRM to the global Roche Pharma field teams." "Roche and Veeva have partnered for many years," said Veeva CEOPeter Gassner. "We are honored to extend our partnership to Vault CRM and bring the next generation of AI-enabled CRM to the global Roche Pharma field teams." "We're…
PR Newswire
24/11/2025

Genmab to Participate in a Fireside Chat at the Citi Global Healthcare…

Media ReleaseCOPENHAGEN, Denmark; November 24, 2025 Genmab A/S (Nasdaq:GMAB)announced today that its Chief Financial Officer Anthony Pagano will participate in a fireside chat at the Citi Global Healthcare Conference in Miamiat 9:45 AMEST(3:45PMCET)on December 4 , 2025 . A webcast of the fireside chat will be available on Genmab’s website athttps://ir.genmab.com/events-presentations. About Genmab Genmab is an...
Nasdaq GlobeNewswire
24/11/2025

Insulin Delivery Devices Market Surges to USD 43.11 Billion by 2033 as Smart…

Technology convergence-where insulin delivery hardware integrates with continuous glucose monitors (CGMs), AI-based dosing algorithms, and smartphone dashboards-continues to drive strong adoption among younger diabetics, tech-savvy patients, and healthcare systems prioritizing long-term glycemic control. Technology convergence-where insulin delivery hardware integrates with continuous glucose monitors (CGMs), AI-based dosing algorithms, and smartphone dashboards-continues to drive strong...
PR Newswire
24/11/2025

Novo Nordisk A/S: Evoke phase 3 trials did not demonstrate a statistically…

Bagsværd, Denmark, 24 November 2025 – Novo Nordisk today announced the top-line results from the 2-year primary analysis of evoke and evoke+ phase 3 trials in early-stage symptomatic Alzheimer’s disease. The two trials were randomised, double-blinded, enrolled a total of 3808 adults and evaluated the efficacy and safety of oral semaglutide compared to placebo on top of standard of care. The decision to pursue an Alzheimer’s disease indication with semaglutide was based on real-world…
Nasdaq GlobeNewswire
24/11/2025

Altibbi Enables Haleon's "Healthy Saudi Smile" Campaign, Turning Oral Health…

The campaign aimed to raise awareness about oral health and preventive care through engaging, science-based educational content. As the digital-health partner, Altibbi transformed this awareness into real access by connecting users directly with certified doctors for instant consultations and trusted medical guidance. The campaign aimed to raise awareness about oral health and preventive care through engaging, science-based educational content. As the digital-health partner, Altibbi…
PR Newswire
24/11/2025

Cell Therapy Market Size Set to More Than Double by 2030 -- North America Leads…

North America continues to lead the global cell therapy market due to strong regulatory pathways, advanced manufacturing infrastructure, and high investment in R&D. The United States remains at the forefront of CAR-T development, allogeneic platform research, and commercialization of next-generation therapies. North America continues to lead the global cell therapy market due to strong regulatory pathways, advanced manufacturing infrastructure, and high investment in R&D.The United...
PR Newswire
24/11/2025

Alvotech Announces Approval of AVT03, a Biosimilar to Prolia® and Xgeva®…

REYKJAVIK, ICELAND (November 25, 2025)— Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the European Commission (EC) has approved AVT03 as a biosimilar to Prolia® and Xgeva® (denosumab).The European denosumab market is currently valued at approximately US$1.2 billion across all indications, based on originator sales in the last 12 months including the second quarter of...
Nasdaq GlobeNewswire
24/11/2025

Sectra at RSNA 2025: Supporting subspecialty workflows and photon-counting CT at…

"Radiologists are drowning in complexity-they need tools that simplify, not add more layers. With integrated photon-counting CT, AI-powered reporting, and subspecialty workflows built into the workstation, Sectra is delivering solutions that don't just reduce strain-they transform diagnostic speed and accuracy. At RSNA 2025, we're showcasing what it means to put radiologists back in control, while pushing patient care to new levels." "Radiologists are drowning in complexity-they…
PR Newswire
24/11/2025

Casino Group presents a detailed overview of “Renouveau 2030” plan and its…

Press ReleaseCasino Group presents a detailed overview of “Renouveau 2030” plan and its project to strengthen financial structure Project to adapt and strengthen Casino Group’s financial structure In support of the execution of its strategic plan, and given the maturity of its debt 1, the Group has initiated work on adapting and strengthening its financial structure. Assisted by the Court appointed administrators overseeing the implementation of the plan and the administrators...
Nasdaq GlobeNewswire
24/11/2025

DXS INTERNATIONAL PLC (AQSE: DXSP): Notice of 2025 Annual General Meeting

Monday 24 November DXS INTERNATIONAL PLC (AQSE: DXSP)Notice of 2025 Annual General Meeting The Board of DXS International plc (“the Company” or “DXSP”), the AQSE Growth Market quoted healthcare information and digital clinical decision support systems provider, is pleased to announce that its Annual General Meeting is scheduled to take place on Thursday 18 thDecember at 11.30 at Elm House, Tanshire Park, Shackleford Road. Elstead, Surrey GU8 6LB.For further information in relation...
Nasdaq GlobeNewswire
24/11/2025

ONWARD Medical Drives Strong US ARC-EX Adoption and Achieves Important…

Commercial traction:The Company met its objective of 40 ARC-EX ®Systems sold in Q3.Regulatory milestones:The US Food and Drug Administration (FDA) approved an investigational device exemption (IDE) for the ARC-IM ®System, allowing the initiation of the Empower BP global pivotal study. The Company received CE Mark certification for the ARC-EX System. In November, the FDA also cleared the ARC-EX System for home use in the US.Science & technology leadership:Key...
Nasdaq GlobeNewswire
24/11/2025

/C O R R E C T I O N -- IEI Integration Corp./

TAIPEI, Nov. 21, 2025 /PRNewswire/ -- IEI Integration Corp. ("IEI"), a global provider of medical and industrial computing platforms, today announced that its New Taipei City (Xizhi) and Qidu (Keelung) facilities have passed inspection by the Taiwan Food and Drug Administration (TFDA) and been awarded Quality Management System (QMS) approval (Xizhi Certificate No. QMS2376、Keelung Certificate No. QMS2377), while maintaining ISO 13485:2016 certification. As one of Taiwan's manufacturers…
PR Newswire
24/11/2025

Sequana Medical Announces First U.S. Commercial alfapump® Implantation at Mount…

Milestone in bringing breakthrough treatment option to US patients with recurrent and refractory ascites due to liver cirrhosisFeedback from hepatology community supports US market potential from this large and growing market driven by obesityKey step in validation of Sequana Medical’s strategy of targeting US transplant centers through its specialty commercial teamContinued strong progress in US commercial roll-outSequana Medical NV (Euronext Brussels: SEQUA, the...
Nasdaq GlobeNewswire
24/11/2025

Fagron strengthens EMEA leadership with acquisitions in Poland and Hungary and…

Regulated information - inside information Nazareth (Belgium)/Rotterdam (The Netherlands), 24 November 2025 – 7:00 AM CET Fagron strengthens EMEA leadership with acquisitions in Poland and Hungary and announces key developments for its North American business Fagron, the global leader in pharmaceutical compounding, has reinforced its EMEA position with the acquisitions of a book of business from Amara (Poland) and Magilab (Hungary). These deals support Fagron’s strategy to diversify its...
Nasdaq GlobeNewswire
24/11/2025

Tony Adams Calls for a National Conversation During Addiction Awareness Week as…

Stigma remains a major barrier to accessing support: among those who have experienced addiction, 35% reported that they would be uncomfortable speaking about it with a close family member; 30% with a friend; 28% with their GP and 27% with their partner. Stigma remains a major barrier to accessing support: among those who have experienced addiction, 35% reported that they would be uncomfortable speaking about it with a close family member; 30% with a friend; 28% with their GP and 27% with their…
PR Newswire
24/11/2025
Altri  Comunicati